← All diseases
Cancer
Liver cancer
Do you want to receive a message when there is new research about Liver cancer? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, one sentence above each publication explains what was studied — and you'll be notified as soon as new research on Liver cancer is available. View what Premium costs.
Publications and studies (3362)
- Psychological Stress Associated Bile Acid Reprogramming Promotes Hepatocellular Carcinoma Progression. (2026/07/11) ♡
- Circulating pre-diagnostic metabolites and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a population-based study of 12 cohorts. (2026/07/10) ♡
- Polyvinyl chloride promotes radioresistance in hepatocellular carcinoma by inhibiting radiotherapy-induced CD8⁺ T cell differentiation. (2026/07/10) ♡
- Target deconvolution of a selective HepG2 cytotoxic hit identifies GSTP1 and TRAP1 as candidate molecular targets. (2026/07/10) ♡
- A label-free magnetic bead affinity approach for direct target identification of herbal extract: Ganoderma lucidum as a case. (2026/07/08) ♡
- Ginsenoside Rh2 Enhances CD8(+) T Cell-Mediated Anticancer Immunity in Hepatocellular Carcinoma. (2026/07/08) ♡
- Direct-Acting Antiviral Therapy and Long-Term Outcomes in Dialysis Patients With Hepatitis C: A Real-world Cohort Study. (2026/07/07) ♡
- Prognostic Value of Skeletal Muscle Loss in Unresectable Hepatocellular Carcinoma Treated with TACE-Based Combination Therapy. (2026/07/07) ♡
- Fluorinated Chitosan-Based Theranostic Nanocarrier System for Image-Guided Synergistic Treatment of Hepatocellular Carcinoma. (2026/07/06) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. A carotenoid-rich functional tomato sauce (OsteoCol®) reduces liver fat content in adults with metabolic dysfunction-associated steatotic liver disease: a randomized clinical trial. (2026/07/03) ♡
- Glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors after liver resection for hepatocellular carcinoma in patients with type 2 diabetes: a target trial emulation study. (2026/07/03) ♡
- Interactive Roles of Metabolic Dysfunction-Associated Steatotic Liver Disease and Nutritional Status in the Prognosis of Patients With Hepatocellular Carcinoma After Surgical Resection. (2026/07/03) ♡
- Argininosuccinate Synthase 1 links hepatic urea cycle to whole body lipid metabolism. (2026/07/03) ♡
- MitoClipSplice: a machine learning framework for resolving mitochondrial RNA cleavage sites from strand-specific RNA-seq soft-clips. (2026/07/03) ♡
- Correction: Polysaccharides-gut microbiota interaction: mechanisms regulating the hepatocellular carcinoma immune microenvironment. (2026/07/03) ♡
- Circulating Methylated SEPT9 for Detection of Hepatocellular Carcinoma in Cirrhosis. (2026/07/02) ♡
- Beyond side effects: treatment-related adverse events are associated with improved survival outcomes in HCC patients on atezolizumab-bevacizumab therapy. (2026/07/02) ♡
- Fuzheng Huayu tablets reduces the risk of further decompensation after the first decompensation in patients with HBV-related cirrhosis: protocol for a randomized, double-blind, placebo-controlled, multicenter trial. (2026/07/02) ♡
- Development and validation of a noninvasive score for at-risk metabolic dysfunction-associated steatohepatitis in individuals with obesity undergoing bariatric surgery. (2026/07/01) ♡
- Preparation and characterisation of two new malonylated rare ginsenosides by acid hydrolysis and their anti-hepatoma activities. (2026/07/01) ♡
- Scutellarin Alleviates Hepatic Steatosis by Autophagy-Mediated NCoR1/PPARα-Driven Fatty Acid β-Oxidation and Enhancing Peroxisome Biogenesis. (2026/07/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Sophora tonkinensis Alleviates Progression of Diethylnitrosamine-Induced Hepatocellular Carcinoma in Rats via Multitarget Regulation. (2026/07/01) ♡
- A multidimensional strategy for identifying quality markers of Radix ginseng-Schisandra chinensis in the disruption of the inflammation-cancer transformation process of hepatocellular carcinoma based on metabolic regulation and chemical properties. (2026/07/01) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Oxymatrine: Hepatoprotective Effects of a Multitarget Natural Alkaloid. (2026/07/01) ♡
- Olaparib alleviates diclofenac-induced toxicity in HepG2 cells via modulation of oxidative stress and mitochondrial functions. (2026/07/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Pre-TIPS Liver and Spleen Volumetry Are Not Associated With Liver-Related Outcomes After TIPS Placement for Refractory Ascites. (2026/07/01) ♡
- Astaxanthin Vesicles Improve Alcoholic Liver Disease Through Oxidative Stress and NF-κB Inflammatory Pathway. (2026/07/01) ♡
- Suspected Khat-associated Cirrhosis: Clinical Characteristics of a 28-patient Case Series from a Khat-endemic Region. (2026/07/01) ♡
- HAX1 Promotes Hepatocellular Carcinoma Progression by Inhibiting Ferroptosis Through Modulation of Iron Homeostasis and the GSH/GPX4 Pathway. (2026/07/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Dynamic nomogram integrating Gd-EOB-DTPA enhanced MRI semantic features, nutritional-inflammatory indices, and early treatment response to predict long-term survival in unresectable HCC treated with interventional, targeted, and immunotherapy: a multicenter retrospective study. (2026/07/01) ♡
- Uncovering cellular perturbations and key mediator communications in liver cancer using single-cell RNA sequencing. (2026/07/01) ♡
- Liver Cancer in Methylmalonic and Propionic Acidemias: A Rare Complication? A Clinico-Pathological Study of 24 Livers. (2026/07/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Hepatitis B in the vaccine era: persistent burden and clinical implications. (2026/07/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Research progress on mechanism of action and clinical applications of quercetin against hepatocellular carcinoma]. (2026/07/01) ♡
- Predicting Recompensation in Alcohol, HBV and HCV-associated Decompensated Cirrhosis. (2026/07/01) ♡
- Aloe emodin isolated from Cassiae semen upregulates IFITM1 to suppress hepatitis B virus replication via the interferon signaling pathway. (2026/06/30) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Metabolic Dysfunction-Associated Fatty Liver Disease: From Pathogenesis to Treatment. (2026/06/30) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Association between the Prognostic Nutritional Index and survival outcomes in hepatocellular carcinoma patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis. (2026/06/30) ♡
- Clinical benefits of tirzepatide in patients with steatotic liver disease and cardiometabolic dysfunction. (2026/06/29) ♡
- Bie-Jia-Jian Pill: Inhibiting tumor glycolysis and promoting CD8(+) cell-mediated anti-tumor immunity by targeting HIF-1α-PI3K/AKT/mTOR and CCL20 in hepatocellular carcinoma. (2026/06/28) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. APASL clinical practice guidelines on the management of chronic hepatitis B infection: a 2026 update. (2026/06/27) ♡
- Inflammatory monocytes constrain YAP-induced cell proliferation. (2026/06/26) ♡
- Global Trends in National Alcohol Control Policies Between 2010-2019. (2026/06/26) ♡
- Development and validation of a nomogram to predict recurrence after hepatectomy in overweight patients with hepatocellular carcinoma: a retrospective cohort study. (2026/06/26) ♡
- Transitions from Combustible to Noncombustible Tobacco Use and Liver Outcomes in Steatotic Liver Disease. (2026/06/25) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Effect of an early time restricted eating Mediterranean diet compared to naltrexone/bupropion on liver fibrosis in people with cardiometabolic risk factors in a hospital outpatient clinic: study protocol for a randomised controlled trial (MEDFAST trial). (2026/06/25) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Regeneration Paradox in Liver Cancer: How Chronic Injury Transforms Healing into Carcinogenesis. (2026/06/25) ♡
- Peripheral and Autonomic Diabetic Neuropathy and Their Additive Risk of Major Adverse Liver Outcomes in Type 2 Diabetes. (2026/06/23) ♡
- Factors associated with cancer-related fatigue in advanced hepatocellular carcinoma patients during the peri-intervention period: a path analysis model. (2026/06/22) ♡
- Genome-wide DNA methylation profiling during metabolic dysfunction-associated steatohepatitis-related hepatocarcinogenesis in patients in Japan and the United States. (2026/06/20) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.